- Home
- DMLP vs BHVN Comparison
DMLP vs BHVN Comparison
Compare DMLP & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DMLP | BHVN |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | United States |
| Employees | 26 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2002 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DMLP | BHVN |
|---|---|---|
| Price | $28.73 | $8.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $29.08 |
| AVG Volume (30 Days) | 160.6K | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 9.98% | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $152,832,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $47.73 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $20.85 | $7.48 |
| 52 Week High | $28.95 | $18.57 |
Technical Indicators
Market Signals| Indicator | DMLP | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 63.97 | 35.81 |
| Support Level | $23.97 | $8.08 |
| Resistance Level | $28.77 | $10.41 |
| Average True Range (ATR) | 0.67 | 0.63 |
| MACD | 0.15 | -0.15 |
| Stochastic Oscillator | 95.82 | 6.45 |
Price Performance
Historical ComparisonAbout DMLP Dorchester Minerals L.P.
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits, and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonuses, and others.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.